Doctors warn of accidental overdosing on herbal medicines
Date published: 06 November 2015
Doctors warn of the dangers posed by herbal remedies after a trained herbalist accidentally overdosed on the "deadly nightshade" herbal medicine, reports the BMJ.
Atropa belladonna, also known as the deadly nightshade, is a poisonous plant that can be purchased legally. In herbal medicine, it is used to treat 'nervous pain' and muscle spasm, and to reduce secretions.
The 50-year-old patient drank a small amount of 50mL from the bottle to help her insomnia one evening. However, this was equivalent to a very large dose of 15mg of atropine - a naturally occurring poison found in A. belladonna - which produced almost fatal effects.
The patient was admitted to the emergency department with acute anticholinergic syndrome - symptoms included confusion, flushes, a fast heart rate, and hypersensitivity. Due to severe agitation, she was sedated, and consequently admitted to intensive care overnight. She made a full recovery by the following morning.
The doctors who treated her write this episode provides an "important insight into potentially dangerous products available legally within the UK." They explain there is no mandatory training or registration for individuals practicing as a herbal practitioners, and minimal legal safeguards or specifications relating to the herbal remedy industry.
Do you have a story for us?
Let us know by emailing news@rochdaleonline.co.uk
All contact will be treated in confidence.
Most Viewed News Stories
- 1'Eyesore’ land in the town centre will become home to new apartment block
- 2Contractor appointed for regeneration scheme in Rochdale town centre
- 3Castleton station ‘to become epicentre of huge change and growth’
- 4Rochdale Exchange Market to reopen after a decade
- 5Decision delayed on 445-home estate in Castleton
To contact the Rochdale Online news desk, email news@rochdaleonline.co.uk or visit our news submission page.
To get the latest news on your desktop or mobile, follow Rochdale Online on Twitter and Facebook.